Managed care and the diffusion of intensity-modulated radiotherapy for prostate cancer

Urology

Volumn 80, Issue 6, 2012, Pages 1236-1242

  Jacobs, Bruce L ^a,b   Zhang, Yun ^b   Skolarus, Ted A ^a,b,c   Wei, John T ^a,b   Montie, James E ^a,b   Schroeck, Florian R ^a,b   Hollenbeck, Brent K ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER REGISTRY; HEALTH CARE UTILIZATION; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICARE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; PROPENSITY SCORE; PROSTATE CANCER; RACE DIFFERENCE; REVIEW;

EID: 84870687409     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2012.09.006     Document Type: Article

References (30)

1. B.L. Jacobs, Y. Zhang, and T.A. Skolarus Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse Health Aff (Millwood) 31 2012 750 759
2. P.L. Nguyen, X. Gu, and S.R. Lipsitz Cost implications of the rapid adoption of newer technologies for treating prostate cancer J Clin Oncol 29 2011 1517 1524
3. J. Staffurth A review of the clinical evidence for intensity-modulated radiotherapy Clin Oncol (R Coll Radiol) 22 2010 643 657
4. N.C. Sheets, G.H. Goldin, and A.M. Meyer Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer JAMA 307 2012 1611 1620
5. A.B. Jani, A. Su, and M.T. Milano Intensity-modulated versus conventional pelvic radiotherapy for prostate cancer: analysis of acute toxicity Urology 67 2006 147 151
6. S.A. Vora, W.W. Wong, and S.E. Schild Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 68 2007 1053 1058
7. J. Carreyrou, and M. Tamman A device to kill cancer, lift revenue Wall Street Journal December 7, 2010 A1
8. C.J. Simon, D. Dranove, and W.D. White The impact of managed care on the physician marketplace Public Health Rep 112 1997 222 230
9. P. Franks, C.M. Clancy, and P.A. Nutting Gatekeeping revisited - protecting patients from overtreatment N Engl J Med 327 1992 424 429
10. J.J. Escarce, D. Polsky, and G.D. Wozniak HMO growth and the geographical redistribution of generalist and specialist physicians, 1987-1997 Health Serv Res 35 2000 825 848
11. C.J. Simon, D. Dranove, and W.D. White The effect of managed care on the incomes of primary care and specialty physicians Health Serv Res 33 1998 549 569
12. L.C. Baker, and C.S. Phibbs Managed care, technology adoption, and health care: the adoption of neonatal intensive care Rand J Economics 33 2002 524 548
13. Centers for Medicare & Medicaid Services (CMS), HHS Medicare Program; Medicare Shared Savings Program: Accountable Care Organizations. Final rule Fed Regist 76 2011 67802 67990
14. S.F. Altekruse, C.L. Kosary, and M. Krapcho SEER Cancer Statistics Review 1975-2007 2010 National Cancer Institute Bethesda, MD
15. C.N. Klabunde, A.L. Potosky, and J.M. Legler Development of a comorbidity index using physician claims data J Clin Epidemiol 53 2000 1258 1267
16. National Center for Health Statistics. Available at: http://www.cdc.gov/ nchs/. Accessed January 3, 2012.
17. J.P. Newhouse Medical care costs: how much welfare loss? J Econ Perspect 6 1992 3 21
18. S. Maxwell, S. Zuckerman, and R.A. Berenson Use of physicians' services under Medicare's resource-based payments N Engl J Med 356 2007 1853 1861
19. L.C. Baker Managed care and technology adoption in health care: evidence from magnetic resonance imaging J Health Econ 20 2001 395 421
20. L.C. Baker Association of managed care market share and health expenditures for fee-for-service Medicare patients JAMA 281 1999 432 437
21. C.L. Bennett, M.R. Bishop, and M.S. Tallman The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: Results from the 1997 American Society of Clinical Oncology survey Ann Oncol 10 1999 1355 1359
22. S. Glied, and J.G. Zivin How do doctors behave when some (but not all) of their patients are in managed care? J Health Econ 21 2002 337 353
23. J. Bian, J. Lipscomb, and M.M. Mello Spillover effects of state mandated benefit laws: the case of outpatient breast cancer surgery Inquiry 46 2009 433 447
24. L.C. Baker The effect of HMOs on fee-for-service health care expenditures: evidence from Medicare J Health Econ 16 1997 453 481
25. Y. Lotan, C. Bolenz, and A. Gupta The effect of the approach to radical prostatectomy on the profitability of hospitals and surgeons BJU Int 105 2010 1531 1535
26. L.C. Baker, and J.E. Spetz Managed care and medical technology growth NBER Working Paper Series Vol. w6894 1999 Available at SSRN: http://ssrn.com/abstract=147169 Accessed January 3, 2012
27. E.W. Correia Accountable care organizations: the proposed regulations and the prospects for success Am J Manag Care 17 2011 560 568
28. D.M. Berwick Making good on ACOs' promise-the final rule for the Medicare shared savings program N Engl J Med 365 2011 1753 1756
29. T.P. Weil Accountable care organizations: HMOs by another name? J Fam Pract 61 2012 10
30. L.C. Baker, and S.W. Atlas Relationship between HMO market share and the diffusion and use of advanced MRI technologies J Am Coll Radiol 1 2004 478 487